Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferriprotoporphyrin IX (FPIX), also known as heme, is a toxic byproduct generated during the digestion of host hemoglobin by Plasmodium falciparum within its acidic food vacuole. To survive, the parasite detoxifies FPIX by sequestering it into an insoluble crystalline form called hemozoin (synthetic equivalent: beta-hematin). This biocrystallization process is a critical survival mechanism for the malaria parasite and serves as a primary target for several classes of antimalarial drugs. Quinolines, such as chloroquine, work by binding to FPIX or the growing crystal surface of hemozoin, thereby preventing further crystallization. The resulting accumulation of free, toxic FPIX leads to oxidative stress, membrane damage, and ultimately the death of the parasite.
Inhibition of hemozoin (beta-hematin) formation/crystallization, leading to the accumulation of toxic free ferriprotoporphyrin IX (FPIX) which causes oxidative stress and membrane damage.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferriprotoporphyrin IX (FPIX) (FPIX).